Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription Articles published in Mod Pathol Retrieve available abstracts of 41 articles: HTML format

Single Articles

April 2024
1. MEDEIROS LJ, Chadburn A, Natkunam Y, Naresh KN, et al
   Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms.
   Mod Pathol. 2024;37:100441.
   PubMed     Abstract available
   
   
   March 2024
2. BATAI B, Kiss L, Varga L, Nagy A, et al
   Profiling of copy number alterations using low-coverage whole-genome sequencing informs differential diagnosis and prognosis in primary cutaneous follicle center lymphoma.
   Mod Pathol. 2024 Mar 7:100465. doi: 10.1016/j.modpat.2024.100465.
   PubMed     Abstract available
   
   
   January 2024
3. SARRO R, Bisig B, Guey B, Missiaglia E, et al
   Follicular lymphoma presenting with symptomatic bone involvement: a clinicopathological and molecular analysis of 16 cases.
   Mod Pathol. 2024 Jan 28:100440. doi: 10.1016/j.modpat.2024.100440.
   PubMed     Abstract available
   
   
   
4. KALINOVA M, Mrhalova M, Kabickova E, Svaton M, et al
   Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling.
   Mod Pathol. 2024 Jan 22:100428. doi: 10.1016/j.modpat.2024.100428.
   PubMed     Abstract available
   
   
   December 2023
5. LI S, Tang G, Jain P, Lin P, et al
   SOX11+ Large B-cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-cell Lymphoma?
   Mod Pathol. 2023 Dec 15:100405. doi: 10.1016/j.modpat.2023.100405.
   PubMed     Abstract available
   
   
   
6. NARESH KN, Medeiros LJ
   Introduction to the Fifth Edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues.
   Mod Pathol. 2023;36:100330.
   PubMed     Abstract available
   
   
   November 2023
7. MEDEIROS LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, et al
   Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].
   Mod Pathol. 2023;36:100355.
   PubMed    
   
   
   October 2023
8. QIU L, Lin P, Khanlari M, Xu J, et al
   The Clinicopathologic Features and Molecular Signatures of Blastoid High-grade B-cell Lymphoma, Not Otherwise Specified.
   Mod Pathol. 2023 Oct 9:100349. doi: 10.1016/j.modpat.2023.100349.
   PubMed     Abstract available
   
   
   September 2023
9. AGOSTINELLI C, Morandi L, Righi S, Cirillo L, et al
   Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets.
   Mod Pathol. 2023 Sep 5:100323. doi: 10.1016/j.modpat.2023.100323.
   PubMed     Abstract available
   
   
   June 2023
10. YOUNES S, Zhao S, Bharadwaj S, Mosquera AP, et al
    Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.
    Mod Pathol. 2023 Jun 28:100256. doi: 10.1016/j.modpat.2023.100256.
    PubMed     Abstract available
    
    
    May 2023
11. HAN B, Yim J, Lim S, Na S, et al
    Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma.
    Mod Pathol. 2023 May 29:100224. doi: 10.1016/j.modpat.2023.100224.
    PubMed     Abstract available
    
    
    April 2023
12. MANSOOR A, Kamran H, Akhter A, Seno R, et al
    "Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways".
    Mod Pathol. 2023 Apr 25:100198. doi: 10.1016/j.modpat.2023.100198.
    PubMed     Abstract available
    
    
    March 2023
13. TAMAKI T, Karube K, Sakihama S, Tsuruta Y, et al
    A Comprehensive Study of the Immunophenotype and its Clinicopathological Significance in Adult T-cell Leukemia/Lymphoma.
    Mod Pathol. 2023 Mar 28:100169. doi: 10.1016/j.modpat.2023.100169.
    PubMed     Abstract available
    
    
    
14. HURWITZ SN, Lockhart B, Onder O, Wu R, et al
    Proteogenomic profiling of high-grade B-cell lymphoma with 11q aberrations and Burkitt lymphoma reveals lymphoid enhancer binding factor 1 as a novel biomarker.
    Mod Pathol. 2023 Mar 28:100170. doi: 10.1016/j.modpat.2023.100170.
    PubMed     Abstract available
    
    
    February 2023
15. BERENDSEN MR, Bladel DAGV, Hesius E, de Groot FA, et al
    Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences.
    Mod Pathol. 2023;36:100119.
    PubMed     Abstract available
    
    
    
16. SESBOUE C, Galtier J, Jeanneau M, Chauvel A, et al
    Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2(-)/BCL6(-) Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma.
    Mod Pathol. 2023;36:100043.
    PubMed     Abstract available
    
    
    January 2023
17. CUTMORE NH, Krupka JA, Hodson DJ
    Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the Challenge.
    Mod Pathol. 2023;36:100007.
    PubMed     Abstract available
    
    
    September 2022
18. GUO J, Cai Y, Wang Z, Xu J, et al
    Double/triple hit lymphoma in the gastrointestinal tract: clinicopathological features, PD-L1 expression and screening strategy.
    Mod Pathol. 2022 Sep 10. pii: 10.1038/s41379-022-01150.
    PubMed     Abstract available
    
    
    
19. BONTOUX C, Simonin M, Garnier N, Lhermitte L, et al
    Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Mod Pathol. 2022;35:1227-1235.
    PubMed     Abstract available
    
    
    August 2022
20. EL HUSSEIN S, Chen P, Medeiros LJ, Hazle JD, et al
    Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia.
    Mod Pathol. 2022;35:1121-1125.
    PubMed     Abstract available
    
    
    July 2022
21. REA B, Liu YC, Maguire A, Soma LA, et al
    Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.
    Mod Pathol. 2022;35:938-945.
    PubMed     Abstract available
    
    
    May 2022
22. GISRIEL SD, Yuan J, Braunberger RC, Maracaja DLV, et al
    Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.
    Mod Pathol. 2022 May 13. pii: 10.1038/s41379-022-01091.
    PubMed     Abstract available
    
    
    
23. ZHANG W, Ao Q, Guan Y, Zhu Z, et al
    A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.
    Mod Pathol. 2022;35:632-639.
    PubMed     Abstract available
    
    
    March 2022
24. NICOLAE A, Bouilly J, Lara D, Fataccioli V, et al
    Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
    Mod Pathol. 2022 Mar 17. pii: 10.1038/s41379-022-01022.
    PubMed     Abstract available
    
    
    
25. VEGA F, Amador C, Chadburn A, Hsi ED, et al
    Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.
    Mod Pathol. 2022;35:306-318.
    PubMed     Abstract available
    
    
    February 2022
26. SADEGHI SHOREH DELI A, Scharf S, Steiner Y, Bein J, et al
    3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma.
    Mod Pathol. 2022 Feb 16. pii: 10.1038/s41379-022-01016.
    PubMed     Abstract available
    
    
    January 2022
27. GIBSON SE, Liu YC, Yatsenko SA, Barasch NJ, et al
    Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.
    Mod Pathol. 2022;35:60-68.
    PubMed     Abstract available
    
    
    December 2021
28. VAN BLADEL DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, et al
    Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.
    Mod Pathol. 2021 Dec 15. pii: 10.1038/s41379-021-00986.
    PubMed    
    
    
    
29. VAN BLADEL DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, et al
    Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.
    Mod Pathol. 2021 Dec 3. pii: 10.1038/s41379-021-00983.
    PubMed     Abstract available
    
    
    November 2021
30. ROH J, Cho H, Pak HK, Lee YS, et al
    BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis.
    Mod Pathol. 2021 Nov 11. pii: 10.1038/s41379-021-00962.
    PubMed     Abstract available
    
    
    
31. RAMIA DE CAP M, Michaels PD
    High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias.
    Mod Pathol. 2021;34:2084.
    PubMed    
    
    
    October 2021
32. KHANLARI M, Li S, Miranda RN, Iyer S, et al
    Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma.
    Mod Pathol. 2021 Oct 9. pii: 10.1038/s41379-021-00944.
    PubMed     Abstract available
    
    
    
33. KHANLARI M, Medeiros LJ, Lin P, Xu J, et al
    Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
    Mod Pathol. 2021 Oct 4. pii: 10.1038/s41379-021-00909.
    PubMed     Abstract available
    
    
    August 2021
34. MARTINEZ-BAQUERO D, Sakhdari A, Mo H, Kim DH, et al
    EZH2 expression is associated with inferior overall survival in mantle cell lymphoma.
    Mod Pathol. 2021 Aug 10. pii: 10.1038/s41379-021-00885.
    PubMed     Abstract available
    
    
    July 2021
35. MEDEIROS LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, et al
    Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
    Mod Pathol. 2021 Jul 5. pii: 10.1038/s41379-021-00863.
    PubMed     Abstract available
    
    
    
36. FOLPE AL
    Response to Lee et al: Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors.
    Mod Pathol. 2021;34:1439.
    PubMed    
    
    
    June 2021
37. EVANS MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, et al
    Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease.
    Mod Pathol. 2021 Jun 21. pii: 10.1038/s41379-021-00842.
    PubMed     Abstract available
    
    
    May 2021
38. DAVIS AR, Stone SL, Oran AR, Sussman RT, et al
    Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice.
    Mod Pathol. 2021;34:904-921.
    PubMed     Abstract available
    
    
    February 2021
39. EGAN C, Lack J, Skarshaug S, Pham TA, et al
    The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.
    Mod Pathol. 2021;34:336-347.
    PubMed     Abstract available
    
    
    
40. YAMADA K, Miyoshi H, Yoshida N, Shimono J, et al
    Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma.
    Mod Pathol. 2021;34:314-326.
    PubMed     Abstract available
    
    
    
41. VELA V, Juskevicius D, Prince SS, Cathomas G, et al
    Deciphering the genetic landscape of pulmonary lymphomas.
    Mod Pathol. 2021;34:371-379.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.